Adderall + Marijuana = Colorado

In July, a revolutionary cannabis based product entered the Colorado cannabis industry and many people have referred to it as the “Adderall of marijuana”. Today, the first reports from Colorado indicate that this product is now sold in every region of the state.

The company behind this product is Cannabics Pharmaceuticals (CNBX), which is a biotech research company that develops its proprietary products out of its GMP certified laboratory in Israel and then licenses the use of these products in the United States. Cannabics does not manufacture, distribute, or dispense any controlled substances, including cannabis or cannabis-based products.

A game changing product

Currently, 15 of the 23 states that legalized medical marijuana only allow for the use of low THC-high CBD products. A number of states also prohibit the use of medical marijuana through smoking and edibles. WanaCapsXR solves this problem by offering patients in these states an alternative method of consumption.

WanaCapsXR are also available in three different ratios of THC and CBD so that patients can select the formulation that best meets their needs and preferences. WanaCaps is offering three different formulations of the product:

• High CBD Capsules with a 10:1 CBD to THC ratio

• High THC Capsules with a 10:1 THC to CBD ratio

• Balanced Capsules with a 1:1 THC to CBD ratio

Itamar Borochov, CEO of Cannabics Pharmaceuticals Inc. said, “The reports from Colorado on increasing sales and returning satisfied customers is an indication to expand into key medical marijuana markets, including New York, Illinois, Washington, Oregon, California and Nevada, through licensing agreements with Wana Brands.”

Outlook

During 2015, shares of CNBX are down 28% and we would be cautious at current levels. As the cannabis industry continues to develop and evolve, these types of products will see increased demand if researchers can validate the efficacy of the product.

Important Investor Disclosures:

Technical 420 LLC, and any of its directors, officers, employees, affiliates, or subsidiaries does not accept any form of compensation from companies in return for writing reports on them. Also Technical 420 LLC, and any of its directors, officers, employees, affiliates, or subsidiaries do not hold any stock positions in companies covered by Technical420LLC. All information relied upon for the above report is publically available via various research resources, including third-party sources we consider reliable, but we do not guarantee that any of such information is accurate or complete. 

Share

Tags

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Technical420.com. Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.

Top Stories